Tundup Smanla, Kandasamy Matheswaran, Perez Jasmine T, Mena Nacho, Steel John, Nagy Tamas, Albrecht Randy A, Manicassamy Balaji
Department of Microbiology, University of Chicago, Chicago, IL, United States of America.
Howard Taylor Ricketts Laboratory, University of Chicago, Argonne, IL, United States of America.
PLoS Pathog. 2017 Mar 10;13(3):e1006270. doi: 10.1371/journal.ppat.1006270. eCollection 2017 Mar.
The cellular and molecular mechanisms underpinning the unusually high virulence of highly pathogenic avian influenza H5N1 viruses in mammalian species remains unknown. Here, we investigated if the cell tropism of H5N1 virus is a determinant of enhanced virulence in mammalian species. We engineered H5N1 viruses with restricted cell tropism through the exploitation of cell type-specific microRNA expression by incorporating microRNA target sites into the viral genome. Restriction of H5N1 replication in endothelial cells via miR-126 ameliorated disease symptoms, prevented systemic viral spread and limited mortality, despite showing similar levels of peak viral replication in the lungs as compared to control virus-infected mice. Similarly, restriction of H5N1 replication in endothelial cells resulted in ameliorated disease symptoms and decreased viral spread in ferrets. Our studies demonstrate that H5N1 infection of endothelial cells results in excessive production of cytokines and reduces endothelial barrier integrity in the lungs, which culminates in vascular leakage and viral pneumonia. Importantly, our studies suggest a need for a combinational therapy that targets viral components, suppresses host immune responses, and improves endothelial barrier integrity for the treatment of highly pathogenic H5N1 virus infections.
高致病性禽流感H5N1病毒在哺乳动物物种中具有异常高毒力的细胞和分子机制仍不清楚。在此,我们研究了H5N1病毒的细胞嗜性是否是其在哺乳动物物种中毒力增强的决定因素。我们通过将微小RNA靶位点整合到病毒基因组中,利用细胞类型特异性微小RNA表达,构建了细胞嗜性受限的H5N1病毒。通过miR-126限制H5N1在内皮细胞中的复制,改善了疾病症状,防止了病毒的全身扩散并降低了死亡率,尽管与对照病毒感染的小鼠相比,肺部病毒复制的峰值水平相似。同样,限制H5N1在内皮细胞中的复制导致雪貂的疾病症状改善和病毒传播减少。我们的研究表明,H5N1感染内皮细胞会导致细胞因子过度产生,并降低肺部内皮屏障的完整性,最终导致血管渗漏和病毒性肺炎。重要的是,我们的研究表明需要一种联合疗法,该疗法靶向病毒成分、抑制宿主免疫反应并改善内皮屏障完整性,以治疗高致病性H5N1病毒感染。